Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

August 05, 2025 07:00 ET | Source: SynOx Therapeutics Limited

SynOx Therapeutics Completes Enrollment in Registrational Phase 3 TANGENT Clinical Trial Significantly Ahead of Timeline

DUBLIN and OXFORD, United Kingdom and PHILADELPHIA, Aug. 05, 2025 (GLOBE NEWSWIRE) -- SynOx Therapeutics Limited (“SynOx”), a late-stage clinical biopharmaceutical company developing emactuzumab for...
August 05, 2025 06:00 ET | Source: FitLife Brands, Inc.

FitLife Brands to Acquire Irwin Naturals

OMAHA, NE, Aug. 05, 2025 (GLOBE NEWSWIRE) -- FitLife Brands, Inc. (“FitLife,” or the “Company”) (Nasdaq: FTLF), a provider of innovative and proprietary nutritional supplements and wellness...
August 05, 2025 04:30 ET | Source: Custom Market Insights

[Latest] Global Third Party Chemical Distribution Market Size/Share Worth USD 460.92 Billion by 2034 at a 4.5% CAGR: Custom Market Insights (Analysis, Outlook, Leaders, Report, Trends, Forecast, Segmentation, Growth Rate, Value, SWOT)

Austin, TX, USA, Aug. 05, 2025 (GLOBE NEWSWIRE) -- Custom Market Insights has published a new research report titled “Third Party Chemical Distribution Market Size, Trends and Insights By Type...
August 04, 2025 08:30 ET | Source: Psyence Biomedical Ltd.

Corporate Update, August 2025

NEW YORK, Aug. 04, 2025 (GLOBE NEWSWIRE) -- From Dr. Neil Maresky, CEO, Psyence BioMed (NASDAQ: PBM) Dear Shareholders, Thank you for your continued support as we advance our mission to develop...
August 04, 2025 04:30 ET | Source: Custom Market Insights

[Latest] Global Door Closer Market Size/Share Worth USD 5.83 Billion by 2034 at a 4.2% CAGR: Custom Market Insights (Analysis, Outlook, Leaders, Report, Trends, Forecast, Segmentation, Growth Rate, Value, SWOT Analysis)

Austin, TX, USA, Aug. 04, 2025 (GLOBE NEWSWIRE) -- Custom Market Insights has published a new research report titled “Door Closer Market Size, Trends and Insights By Product (Mechanical,...
August 01, 2025 08:30 ET | Source: Allogene Therapeutics, Inc.

Allogene Therapeutics Moves Forward with Standard Fludarabine and Cyclophosphamide (FC) Lymphodepletion Regimen in the ALPHA3 Trial for Cemacabtagene Ansegedleucel (Cema-Cel) in First-Line Consolidation for Large B-Cell Lymphoma

Lymphodepletion Regimen Selection Made in Conjunction with the ALPHA3 Data and Safety Monitoring Board (DSMB) and Steering Committee, and in Consultation with the FDA Following an ALLO-647-Related...
July 31, 2025 01:00 ET | Source: CREDIT AGRICOLE SA

Credit Agricole Sa: Results for the second quarter and first half 2025 - The Group is accelerating its development

THE GROUP IS ACCELERATING ITS DEVELOPMENT CRÉDIT AGRICOLE S.A. CRÉDIT AGRICOLE GROUP €m Q2 2025 Change Q2/Q2 Q2 2025 Change Q2/Q2 Revenues 7,006 ...
July 30, 2025 11:00 ET | Source: Biogen Inc.

Two-Year Real-World Study of LEQEMBI® in the United States Presented at Alzheimer's Association International Conference (AAIC) 2025

TOKYO and CAMBRIDGE, Mass., July 30, 2025 (GLOBE NEWSWIRE) -- Eisai Co., Ltd. (Headquarters: Tokyo, CEO: Haruo Naito, “Eisai”) and Biogen Inc. (Nasdaq: BIIB, Corporate headquarters: Cambridge,...
July 30, 2025 08:00 ET | Source: LENZ Therapeutics, Inc.

LENZ Therapeutics Reports Second Quarter 2025 Financial Results and Recent Corporate Highlights

New Drug Application (NDA) for LNZ100 for treatment of presbyopia on track for PDUFA target action date of August 8, 2025 88-member sales force hired and prepared to initiate sales and...
July 30, 2025 04:30 ET | Source: Custom Market Insights

[Latest] Global Lenacapavir Injection Market Size/Share Worth USD 5.68 Billion by 2034 at a 5.1% CAGR: Custom Market Insights (Analysis, Outlook, Leaders, Report, Trends, Forecast, Segmentation, Growth Rate, Value, SWOT Analysis)

Austin, TX, USA, July 30, 2025 (GLOBE NEWSWIRE) -- Custom Market Insights has published a new research report titled “Lenacapavir Injection Market Size, Trends and Insights By Indication (HIV...